TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $8,388,000 | -15.6% | 126,266 | -0.8% | 0.29% | -10.8% |
| Q2 2021 | $9,935,000 | -43.4% | 127,345 | -31.4% | 0.32% | -44.3% |
| Q1 2021 | $17,562,000 | -57.1% | 185,665 | -44.8% | 0.58% | -59.1% |
| Q4 2020 | $40,963,000 | +66.0% | 336,173 | +19.0% | 1.42% | +30.3% |
| Q3 2020 | $24,674,000 | +95.4% | 282,440 | +44.5% | 1.09% | +83.6% |
| Q2 2020 | $12,628,000 | +488.2% | 195,503 | +306.6% | 0.60% | +341.5% |
| Q1 2020 | $2,147,000 | – | 48,083 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |